Postmortem immunocytochemistry confirmed the activation of microglia and astrocytes in FTD-GRN patient brains, along with abundant complement C1qa deposits particularly in the frontal cortex, increased inflammatory markers, and more pronounced gliosis in the frontal cortex than in the thalamus [7, 16]. The gene discussed is C1QA; the disease is frontotemporal dementia.